UNIQURE CLASS ACTION LAWSUIT 2006: A HELPFUL INVESTOR GUIDE
If you purchased or acquired shares of uniQure stock between September 24, 2025 and October 31, 2025, and suffered a loss you are most likely a member of the class. Call Timothy L. Miles for more information about the lead plaintiff process or any other questions you may have at no charge. 855-846-6529 or [email protected]
Introduction to the uniQure Class Action Lawsuit
- Who is Affected by the uniQure class action lawsuit? All purchasers or acquirers of uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025 inclusive (the “Class Period”).
- The Problem: The uniQure class action lawsuit alleges the defendant made false and misleading statements driving the stock price artificially up until the truth emerged and the stock plummeted and shareholders who purchased during the relevant time period and suffered a loss are entitle to damages
- Your Action: You may be eligible to recover your losses in a uniQure class action lawsuit
- Deadline to Lead: The deadline to apply to be Lead Plaintiff is April 13, 2026.
How it Works
A lawsuit is initiated by one or more investors, called the “lead plaintiffs,” on behalf of a larger group of investors, or the “class”.
- The “class period” is defined as the specific timeframe during which the alleged fraudulent activity took place. Only those who bought or sold the security during this period are eligible to participate.
- A lead plaintiff is appointed to represent the class. Under the Private Securities Litigation Reform Act (PSLRA), the court will typically appoint the investor with the largest financial interest in the outcome of the case.
- The case is litigated, which may include a lengthy discovery phase for gathering evidence.
- The case can be settled or go to trial. Most class actions are resolved through settlements, which can include cash or stock paid into a common fund for the class. The lead plaintiff and class counsel approve any settlement before it is finalized.
Common Types of Misconduct
- Securities fraud class actions can arise from various types of misconduct by a company, its officers, or others involved in the sale of its securities, including:
- Making false or misleading statements in SEC filings, prospectuses, or earnings announcements.
- Overstating a company’s revenues or profits through fraudulent or “creative” accounting.
- Failing to disclose material information that would significantly alter an investor’s view.
- Engaging in market manipulation to artificially inflate or deflate a security’s price.
What Plaintiffs Must Prove
To succeed in a federal securities fraud class action, plaintiffs must prove several elements:
- Material misstatement or omission: The company made a false or misleading statement, or failed to disclose a material fact.
- Scienter: The defendant acted with an intent to deceive, manipulate, or defraud.
- Reliance: The plaintiff relied on the misstatement or omission when buying or selling the security. For publicly traded securities, this can be proven through the “fraud-on-the-market” theory, which presumes the market price reflects all public, material information.
- Economic loss: The plaintiff suffered a financial loss.
- Loss causation: The company’s misstatement or omission directly caused the plaintiff’s loss, often demonstrated by a stock price drop after the truth is revealed in a “corrective disclosure”
Benefits for Investors
- Participating in a class action allows investors to pool their resources, which offers leverage they would not have in an individual lawsuit against a large corporation.
- The collective approach also makes it more efficient and cost-effective to pursue legal action, especially for smaller investors.
How to Get Involved
- If you bought a security during the alleged class period and suffered a loss, you are generally automatically included in the class. You don’t have to take any action unless you want to file a claim for recovery later.
- You may be notified of a class action by mail if you are an eligible class member.
- You may be able to become a lead plaintiff by applying within 60 days of the first lawsuit being announced.
- If you believe you may have a claim, you can contact a securities class action law firm for guidance.
Allegations in the uniQure Class Action Lawsuit
uniQure develops treatments for patients suffering from rare and other devastating diseases. The complaint alleges that uniQure’s leading drug candidate is AMT-130, a novel gene therapy being developed to slow the progression of Huntington’s disease.
The uniQure class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) the design of uniQure’s Pivotal Study – including comparison of the Pivotal Study results to the ENROLL-HD external historical data set – was not fully approved by the U.S. Food and Drug Administration (“FDA”); and (ii) defendants downplayed the likelihood that, despite purportedly highly successful results from the AMT-130 Pivotal Study, uniQure would have to delay its Biologics License Application (“BLA”) timeline to perform additional studies to supplement its BLA submission.
The uniQure class action lawsuit further alleges that on November 3, 2025, uniQure revealed that the FDA “currently no longer agrees that data from the Phase I/II studies of AMT-130 in comparison to [the ENROLL-HD] external control, as per the prespecified protocols and statistical analysis plans shared with the FDA in advance of the analyses, may be adequate to provide the primary evidence in support of a BLA submission.”
As a result, uniQure allegedly stated that “the timing of the BLA submission for AMT-130 is now unclear,” but that uniQure “plans to urgently interact with the FDA to find a path forward for the timely accelerated approval of AMT-130.” On this news, the price of uniQure ordinary shares fell more than 49%, according to the uniQure class action lawsuit.
TIMOTHY L. MILES | FREE CASE EVALUATION
Options Available to Shareholders
- Do Nothing (Remain a Class Member): This is the most common option. If you take no action, you automatically remain a member of the class.
- Exclude Yourself (Opt-Out): You have the absolute right to exclude yourself from the class action. This is often referred to as “opting out.”
- How to Exclude Yourself (Opt-Out): The process for opting out is not available immediately, but only when the class has been formally certified and a settlement or trial is imminent.
- Wait for the Class Notice: If a settlement is reached, the court will approve a Notice of Proposed Settlement that is mailed to all known class members.
- Review the Notice: This document will contain specific, formal instructions on how to exclude yourself from the settlement.
- Submit a Written Request: You must draft and mail a letter stating clearly that you wish to be excluded from the class action, and include all identifying information (name, address, shares sold, etc.).
- Meet the Deadline: Your exclusion request must be postmarked by the deadline in the Notice.
Lead Plaintiff Information
The Lead Plaintiff is the person or entity appointed by the court to represent the entire class in a securities class action or shareholder lawsuit.
This role involves a fiduciary duty to act in the best interests of all class members, making significant decisions throughout the litigation process.
To be appointed, a shareholder typically must show they have the largest financial interest in the relief sought and are capable of adequately protecting the class.
The deadline to move for appointment as Lead Plaintiff is strictly 60 days from the date the first class action notice is published.
Rights of Investors
Investors affected by the uniQure class action lawsuit possess specific rights that they can exercise. Understanding these rights is vital for anyone considering involvement in the lawsuit.
Right to Information
- Investors have the right to receive accurate and timely updates regarding the uniQure lawsuit.
- This includes information on the case’s progress, potential settlements, and any necessary actions they may need to undertake.
Right to Participate
- Affected investors have the right to join the uniQure class action lawsuit.
- This allows them to collaborate with other investors in seeking compensation for their losses without the burden of filing individual lawsuits.
Right to Legal Representation
- Investors can seek legal counsel to navigate the complexities of the uniQure class action lawsuit.
- Legal professionals can provide guidance and support throughout the process.
- If you suffered substantial losses and wish to serve as lead plaintiff of the uniQure class action lawsuit or just have general questions about you rights as a shareholder, please contact attorney Timothy L. Miles of the Law Offices of Timothy L. Miles, at no cost, by calling 855/846-6529 or via e-mail at [email protected].
Contingency Fee Agreements: No Cost to Hire a Lawyer
- No Fee: It does not cost anything to hire a lawyer if you are eligible for a uniQure class action lawsuit. We take all cases on a contingency basis which means we do not get paid unless we win or settle your case.
- Talk with a Lawyer Free of Charge: A lawyer can explain the process of a uniQure class action lawsuit and answer any questions you may have free of charge.
Frequently Asked Questions About the uniQure Class Action Lawsuit
What initiated the uniQure class action lawsuit?
The uniQure class action lawsuit is initiated by investors alleging that uniQure provided misleading information regarding its financial health and operations, resulting in financial losses.
How can I join the uniQure lawsuit?
If you purchased shares during the class period and suffered a loss, then you are automatically a member of the uniQure class action lawsuit and do not need to do anything at this point unless you are considering moving for lead plaintiff.
What are the potential benefits of a uniQure lawsuit?
Class action lawsuits like the uniQure lawsuit allow individual investors to collectively seek justice and compensation, which might be challenging to pursue individually. They also promote corporate accountability.
How long will the uniQure class action lawsuit take to resolve?
The duration of class action lawsuits can vary significantly, depending on the complexity of the case, legal strategies, and whether settlements are reached. It could take several months to years to resolve the lawsuit.
Contact Timothy L. Miles Today About a uniQure Class Action Lawsuit
The most important thing you need to know is you can call me at no charge if you wish to serve as lead plaintiff of the uniQure class action lawsuit, or just have general questions about you rights as a shareholder, please contact attorney Timothy L. Miles of the Law Offices of Timothy L. Miles, at no cost, by calling 855/846-6529 or via e-mail at [email protected]. (24/7/365).
Timothy L. Miles, Esq.
Law Offices of Timothy L. Miles
Tapestry at Brentwood Town Center
300 Centerview Dr. #247
Mailbox #1091
Brentwood,TN 37027
Phone: (855) Tim-MLaw (855-846-6529)
Email: [email protected]
Website: www.classactionlawyertn.com
Facebook Linkedin Pinterest youtube
Visit Our Extensive Investor Hub: Learning for Informed Investors
